Patents by Inventor Mohammed Amin Khan

Mohammed Amin Khan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR ADMINISTERING GLP-1 MOLECULES
    Publication number: 20150202296
    Abstract: The invention relates to formulations that demonstrate the feasibility of oral absorption comprising glucose-like peptide-1 compounds and specified delivery agents, and to methods of stimulating GLP-1 receptor in a subject in need of such stimulation, by administration of the formulation of the present invention.
    Type: Application
    Filed: January 22, 2015
    Publication date: July 23, 2015
    Inventors: Mohammed Amin KHAN, Bryan Edward Jones, John Mcneill McGill
  • METHOD FOR ADMINISTERING GLP-1 MOLECULES
    Publication number: 20140005106
    Abstract: The invention relates to formulations that demonstrate the feasibility of oral absorption comprising glucose-like peptide-1 compounds and specified delivery agents, and to methods of stimulating GLP-1 receptor in a subject in need of such stimulation, by administration of the formulation of the present invention.
    Type: Application
    Filed: July 16, 2013
    Publication date: January 2, 2014
    Applicant: Emisphere Technologies, Inc.
    Inventors: Mohammed Amin KHAN, Bryan Edward Jones, John Mcneill McGill
  • Formulation comprising GLP-1
    Patent number: 8492330
    Abstract: The invention relates to formulations that demonstrate the feasibility of oral absorption comprising glucose-like peptide-1 compounds and specified delivery agents, and to methods of stimulating GLP-1 receptor in a subject in need of such stimulation, by administration of the formulation of the present invention.
    Type: Grant
    Filed: January 12, 2011
    Date of Patent: July 23, 2013
    Assignee: Emisphere Technologies, Inc.
    Inventors: Mohammed Amin Khan, Bryan Edward Jones, John McNeill McGill
  • Method for administering GLP-1 molecules
    Patent number: 7939494
    Abstract: The invention relates to formulations that demonstrate the feasibility of oral absorption comprising glucose-like peptide-1 compounds and specified delivery agents, and to methods of stimulating GLP-1 receptor in a subject in need of such stimulation, by administration of the formulation of the present invention.
    Type: Grant
    Filed: April 9, 2009
    Date of Patent: May 10, 2011
    Assignee: Emisphere Technologies, Inc.
    Inventors: Mohammed Amin Khan, Bryan Edward Jones, John McNeill McGill
  • METHOD FOR ADMINISTERING GLP-1 MOLECULES
    Publication number: 20090286735
    Abstract: The invention relates to formulations that demonstrate the feasibility of oral absorption comprising glucose-like peptide-1 compounds and specified delivery agents, and to methods of stimulating GLP-1 receptor in a subject in need of such stimulation, by administration of the formulation of the present invention.
    Type: Application
    Filed: April 9, 2009
    Publication date: November 19, 2009
    Inventors: Mohammed Amin Khan, Bryan Edward Jones, John McNeill McGill